N/A
N/A, United Kingdom
Dr Stella Blackburn. MB BS, MA, MSc, FRCP(Ed), FISPE, FFPM, DLSHTM, Dip Pharm Med.
Stella studied medicine at Cambridge and Guys and worked in hospital medicine before joining the pharmaceutical industry. She has worked in pharmacovigilance and pharmacoepidemiology for 35 + years: in industry (11+ years) as a regulator (nearly 17 years) and CRO (9 years). She has an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine and co-developed their course in Pharmacovigilance and Pharmacoepidemiology. In 1997 she joined the European Medicines Agency (EMA). Stella developed EU strategy and policy on risk management, writing the EU guidelines on this topic and was part of the core team implementing the 2010 PhV legislation. She was on the original steering group developing ENCEPP and was the Alternate Co-ordinator, and a scientific work package leader, of IMI PROTECT. She is/was on the CIOMS IX/XI/XIII working parties and is a member of the CIOMS Executive Committee and Glossary Advisory Group. She currently advises companies on EU strategy, Post Authorisation Safety Studies and risk management and has a special interest in rare diseases.
Stella is a Fellow of the International Society of Pharmacoepidemiology (ISPE), the Royal College of Physicians of Edinburgh, and the Faculty of Pharmaceutical Medicine. She is a past President of ISPE, an Honorary Professor at the LSHTM and works with NEWDIGS, Center for Biomedical System Design at Tufts.
Disclosure information not submitted.
Patient Involvement in the Development and Safe Use of Medicines
Saturday, August 26, 2023
10:00 AM – 11:30 AM ADT
